Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
{{output}}
Inhibition of the signal transducer and activator of transcription 3 (STAT3) signalling pathway has been considered as a novel therapeutic strategy to treat human cancers with constitutively active STAT3. In this study, we screened 1563 compounds and identifie... ...
